Tandem Diabetes Care | TNDM - Trade Creditors


Tandem Diabetes Care reported $59.86M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Accuray USD 43.52M 1.12M Dec/2025
Align Technology USD 123.72M 2.27M Mar/2026
AtriCure USD 70.06M 8.34M Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Becton, Dickinson and Co. USD 5.93B 204M Mar/2026
Boston Scientific USD 1.14B 3M Mar/2026
Cooper Companies USD 233.3M 7.5M Mar/2026
Dexcom USD 1.94B 109.1M Mar/2026
Edwards Lifesciences USD 181.1M 46.4M Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Globus Medical USD 103.66M 4.81M Mar/2026
ICU Medical USD 173.98M 19.61M Mar/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 149.8M 74.8M Mar/2026
Integra LifeSciences USD 87.95M 7.78M Mar/2026
Intuitive Surgical USD 1.85B 68.6M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Masimo USD 89M 14M Mar/2026
Medtronic USD 2.57B 12M Dec/2025
Merit Medical Systems USD 67.85M 7.3M Mar/2026
Orthofix International USD 54.69M 3.71M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Stryker USD 1.8B 301M Dec/2025
Tandem Diabetes Care USD 59.86M 12.79M Mar/2026
Teleflex USD 143.63M 13.43M Mar/2026
Zimmer Biomet Holdings USD 361.2M 58.2M Mar/2026